Category archive
Browse every WeightEasy article in the Access & Affordability category.
Category pages gather broader article themes, which makes them useful for readers who are exploring a whole area like injection routines, side effects, or dose tracking rather than a single narrow question.
GLP 1 medications have transformed obesity and diabetes care in the United States and Europe. The same drugs are now becoming more widely available in India though access, pricing,...
On February 24, 2026, Novo Nordisk announced something that would have seemed unlikely two years ago: a major price cut on its entire semaglutide portfolio Wegovy, Ozempic, and Ryb...